17 to 18 December 2014

Red Rooms City Tower, Piccadilly Plaza, Manchester

Clinical Guidelines Updates Standing Committee Meeting (Committee A) : Wednesday 17 and Thursday 18 December 2014

 

Wednesday 17 December 2014 (Day 1) - The meeting will start promptly at 10:10 and is expected to finish at approximately 16:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introductions - Part 1 only (open session)

2. Code of Conduct for members of the public attending the meeting- Part 1 only (open session)

3. Declarations of Interest - Part 1 only (open session)

4. Irritable bowel syndrome:

  • Are low-dose antidepressants effective in the management of IBS? and of these, are any more effective than others?
  • Is relaxation therapy effective in the management of IBS symptoms?
  • Is a low FODMAP diet effective in the management of IBS symptoms?
  • Is linaclotide effective in the treatment of IBS-constipation?
  • Is lubiprostone effective in the treatment of IBS-constipation?
  • Are psychological therapies effective in the management of IBS symptoms?

          (Post consultation comments) - Part 1 only (open session)

5. Standing committee member training - Part 2 only (closed session)                                                                                                                                 

                                                               

                                                                            End of Day 1

 

Thursday 18 December 2014 (Day 2) - The meeting will start promptly at 10:10 and is expected to finish at approximately 16:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

 1. Welcome and introductions - Part 1 only (open session)

 2. Code of Conduct for members of the public attending the meeting - Part 1 only (open session)

 3. Declarations of Interests - Part 1 only (open session)

 4. The management of lower urinary tract symptoms in men:

  • What is the clinical and cost-effectiveness of phosphodiesterase 5 inhibitors alone in the treatment of LUTS? - Part 1 only (open session)

5. Draft recommendations - Part 2 only (closed session)

 

                                                                            End of Day 2

 

 

Date, time and venue of next meeting: 12 & 13 March 2015, 10:00am, City Tower Level 1, Piccadilly Plaza, Manchester, M1 4BT

 

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

 

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

 

The closing date for registration is Wednesday 03 December 2014. Please note that it may not be possible to accept late registration requests.

 

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sandra Robinson at sandra.robinson@nice.org.uk

 

 

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

Registration period: 19 November 2014 to 03 December 2014
Registration is closed.